Stanford University


Showing 341-350 of 2,460 Results

  • Kateryna Chernohorenko

    Kateryna Chernohorenko

    Affiliate, FSI

    BioKateryna Chernohorenko is the architect of Ukraine’s digital transformation and the former Deputy Minister of Defense of Ukraine (2023-2025).

    During her government tenure, Kateryna Chernohorenko spearheaded systemic reforms that fortified Ukraine’s institutions and redefined modern warfare:

    • Launched Reserve+, a mobile app for conscripts and reservists that digitised military records and integrated recruitment functionality (6M+ users);
    • Launched Army+, a dedicated mobile app for active military personnel featuring e-reports, training courses, surveys, discount programs, and cross-unit transfer functionality (1M+ users);
    • Scaled DELTA, a Ukrainian battlefield management system — officially certified according to the NATO standards and used by 90% of the Armed Forces’ units;
    • Formed and led the Drone and IT coalitions, mobilising over $3.3 billion in military aid.
    • Established the Cyber Incident Response Center, securing 24/7 monitoring of Ukrainian cyberspace, preventing data breaches, and ensuring the country’s digital resilience.
    • Initiated the creation of the Space Policy Directorate within the Ministry of Defense, laying the legal and institutional foundation for global space security integration.

    Currently, Kateryna Chernohorenko serves as a strategic advisor to the global and Ukrainian defense tech industry, providing guidance on digital development and drone warfare. She also shares her expertise as a Senior Lecturer at the National University of Kyiv-Mohyla Academy, teaching the course “E-Governance, Document Management, and Digital Democracy”, and authors a “Chief Strategic Officer in Defence” aimed at C-level managers in the defense industry.

  • Mike Cherry

    Mike Cherry

    Professor (Research) of Genetics, Emeritus

    Current Research and Scholarly InterestsMy research involves identifying, validating and integrating scientific facts into encyclopedic databases essential for research and scientific education. Published results of scientific experimentation are a foundation of our understanding of the natural world and provide motivation for new experiments. The combination of in-depth understanding reported in the literature with computational analyses is an essential ingredient of modern biological research.

  • Glenn M. Chertow

    Glenn M. Chertow

    Norman S. Coplon/Satellite Healthcare Professor of Medicine and Professor, by courtesy, of Epidemiology and Population Health and of Health Policy

    Current Research and Scholarly Interestsclinical epidemiology, health services research, decision sciences, clinical trials in acute and chronic kidney disease

  • Emilie Cheung, MD

    Emilie Cheung, MD

    Associate Professor of Orthopaedic Surgery

    Current Research and Scholarly InterestsPyrocarbon humeral head replacement
    Clinical outcome after shoulder replacement
    Clinical outcome after elbow replacement
    Clinical outcomes following complex reconstruction of the shoulder and elbow,
    Bone mineral density in the shoulder,
    3D kinematics of the shoulder girdle after arthroplasty

  • E.J. Chichilnisky

    E.J. Chichilnisky

    John R. Adler Professor, Professor of Neurosurgery and of Ophthalmology and, by courtesy, of Electrical Engineering

    Current Research and Scholarly InterestsFunctional circuitry of the retina and design of retinal prostheses

  • Allis Chien

    Allis Chien

    Affiliate, Mass Spectrometry Center

    Current Role at StanfordEmeritus Staff:
    Director, Stanford University Mass Spectrometry (SUMS) core resource laboratory
    Staff Director, Stanford School of Medicine Service Centers

  • Yueh-hsiu Chien

    Yueh-hsiu Chien

    Professor of Microbiology & Immunology

    Current Research and Scholarly InterestsContribution of T cells to immunocompetence and autoimmunity; how the immune system clears infection, avoids autoimmunity and how infection impacts on the development of immune responses.

  • Gheorghe Chistol

    Gheorghe Chistol

    Assistant Professor of Chemical and Systems Biology

    Current Research and Scholarly InterestsResearch in my laboratory is aimed at understanding how eukaryotes replicate their DNA despite numerous challenges (collectively known as replication stress), and more generally – how eukaryotic cells safeguard genome integrity. Specifically, we are investigating: (i) mechanisms that regulate the activity of the replicative helicase during replication stress, (ii) mechanisms that control the inheritance of epigenetic information during replication, and (iii) mechanisms of ubiquitin-mediated regulation of genome maintenance. We utilize single-molecule microscopy to directly image fluorescently-labeled replication factors and track them in real time in Xenopus egg extracts. I developed this system as a postdoctoral fellow, and used it to monitor how the eukaryotic replicative helicase copes with DNA damage. We plan to further extend the capabilities of this platform to directly visualize other essential replication factors, nucleosomes, and regulatory post-translational modifications like ubiquitin chains. By elucidating molecular mechanisms responsible for maintaining genome stability, we aim to better understand the link between genome instability and cancer, and how these mechanisms can be harnessed to improve disease treatment.

  • Bill Chiu

    Bill Chiu

    Associate Professor of Surgery (Pediatric Surgery)

    BioDr. Chiu obtained his B.S. degree in Biological Sciences and graduated with Honors from Stanford University. After graduating, he received his Medical Degree at Northwestern University Feinberg School of Medicine, where he remained for his internship and General Surgery residency training. Dr. Chiu completed his Pediatric Surgery training at The Children’s Hospital of Philadelphia. He is an Associate Professor at Stanford University School of Medicine where he has an active research program studying innovative approaches to treat patients with neuroblastoma.